在2型糖尿病患者服用-葡萄糖辅运输体-2抑制剂时,血清的变化
Kellye Eagan1, Charlotte Bolch2, Elizabeth Van Dril3
1Riverside Medical Center, Kankakee, Illinois, USA.
Pharmacotherapy
|February 24, 2025
概括
在2型糖尿病 (T2D) 患者中,-葡萄糖共运输体-2 (SGLT2) 抑制剂治疗没有导致水平的临床显著变化. 基线值不应阻止SGLT2抑制剂在适当时使用.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- -葡萄糖共载体-2 (SGLT2) 抑制剂是一种用于治疗2型糖尿病 (T2D) 的药物.
- 有关SGLT2抑制剂对血清电解质水平,特别是的潜在影响存在担忧.
- 了解电解质变化对于安全有效的糖尿病管理至关重要.
研究的目的:
- 为了确定SGLT2抑制剂治疗是否会导致T2D患者水平的显著变化.
- 为了确定患者特异性因素,这些因素可能会使个人在SGLT2抑制剂治疗期间容易发生水平变化.
主要方法:
- 对2型糖尿病患者处方SGLT2抑制剂的多中心回顾性队列图表审查.
- 纳入标准:T2D诊断,使用SGLT2抑制剂 (canagliflozin,dapagliflozin,empagliflozin或 ertugliflozin) 至少7天.
- 排除标准:在指定的时间范围内缺乏基线或后续代谢面板数据.
主要成果:
- 1926名患者从6425名初始队列中满足了纳入标准.
- 随着达帕格利弗洛辛 (p=0.018) 的使用,观察到的变化具有统计学意义,但没有临床意义.
- 与基线相比,血清的总体平均变化在不同的随访期内 (在3个月内,3至5.9个月,6至12个月,>12个月) 是最小的.
结论:
- 在T2D患者中启用SGLT2抑制剂不会导致临床显著的水平变化.
- 这一发现与背景药物使用或患者特定因素无关,是一致的.
- 在临床上显示时,基线水平不应是启动SGLT2抑制剂治疗的禁忌.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
437
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
437
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Regulation of Sodium and Potassium
374
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
374
Antihypertensive Drugs: Action of Diuretics
611
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
611
Oral Hypoglycemic Agents: Biguanides and Glitazones
158
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
158


